Long-term efficacy of dose intensified interferon-α 2b and ribavirin therapy for hepatitis C in HIV-coinfected patients

被引：0
|
作者：
Mannah, M [1 ]
Rockstroh, JK [1 ]
Gölz, J [1 ]
Klausen, G [1 ]
Dupke, S [1 ]
Stein, L [1 ]
Notheis, G [1 ]
Stoehr, A [1 ]
Mauss, S [1 ]
机构：
[1] Univ Bonn, Neurol Klin, D-53105 Bonn, Germany
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W901
引用
收藏
页码：A528 / A528
页数：1
相关论文
共 50 条
  • [41] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis C A Meta-Analysis
    Flori, Nicolas
    Funakoshi, Natalie
    Duny, Yohan
    Valats, Jean-Christophe
    Bismuth, Michael
    Christophorou, Dimitri
    Daures, Jean-Pierre
    Blanc, Pierre
    DRUGS, 2013, 73 (03) : 263 - 277
  • [42] National multicenter study of eligibility for interferon and ribavirin therapy in patients coinfected with HIV and hepatitis C
    Bini, EJ
    Currie, S
    Shen, H
    Brau, N
    Schmidt, W
    Wright, TL
    GASTROENTEROLOGY, 2004, 126 (04) : A695 - A695
  • [43] Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV
    Rallon, Norma I.
    Soriano, Vincent
    Naggie, Susanna
    Restrepo, Clara
    McHutchison, John
    Vispo, Eugenia
    Benito, Jose M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (05) : 1246 - 1249
  • [44] Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients
    Pineda, Juan A.
    Mira, Jose A.
    de los Santos Gil, Ignacio
    Valera-Bestard, Barbara
    Rivero, Antonio
    Merino, Dolores
    Giron-Gonzalez, Jose A.
    Rios-Villegas, Maria J.
    Gonzalez-Serrano, Mercedes
    Collado, Antonio
    Garcia-Garcia, Jose A.
    Carrillo-Gomez, Raquel
    Lopez-Cortes, Luis F.
    Gomez-Mateos, Jesus
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (06) : 1347 - 1354
  • [45] Safety and efficacy of pegylated interferon (peg INF)-alfa-2b plus ribavirin (RBV) for the treatment of chronic hepatitis C in HIV-coinfected patients: 48 week results
    Voigt, E
    Schulz, C
    Klausen, G
    Goetz, J
    Mauss, S
    Mutz, A
    Mosthaf, FA
    Lauenroth-Mai, E
    Rockstroh, JK
    GASTROENTEROLOGY, 2003, 124 (04) : A767 - A767
  • [46] Efficacy and safety of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients
    Landau, AO
    Batisse, DP
    van Huen, PD
    Piketty, C
    Bloch, F
    Pialoux, G
    Petite, JP
    Weiss, L
    Kazatchkine, M
    HEPATOLOGY, 1999, 30 (04) : 367A - 367A
  • [47] Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C
    Sakai, T
    Shiraki, K
    Inoue, H
    Okano, H
    Deguchi, M
    Sugimoto, K
    Ohmori, S
    Murata, K
    Nakano, T
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2002, 10 (02) : 201 - 204
  • [48] Efficacy of interferon alpha-2b plus ribavirin combination therapy in HIV/HCV coinfected patients
    Oliver, DL
    Stewart, M
    Chatfield, E
    Aronson, N
    Selim, K
    Mathew, C
    Hassanein, T
    GASTROENTEROLOGY, 2002, 123 (01) : 77 - 77
  • [49] Emotional distress during interferon-α-2B and ribavirin treatment of chronic hepatitis C
    Fontana, RJ
    Schwartz, SM
    Gebremariam, A
    Lok, ASF
    Moyer, CA
    PSYCHOSOMATICS, 2002, 43 (05) : 378 - 385
  • [50] Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort
    Alvarez-Uria, G.
    Ratcliffe, L.
    Vilar, J. F.
    HIV MEDICINE, 2009, 10 (05) : 269 - 273
12345